The proposed acquisition will be the company’s biggest deal in more than a decade and represents an early move by new CEO Kai ...

Bio-Rad posts robust margins and liquidity, while Charles River leads in global drug discovery services. Explore how their ...

From startups to giants in pharma and tools, the use of spatial biology is growing in importance in drug discovery. LatchBio, a four-year-old San Francisco builder of software and data infrastructure ...

Artificial intelligence is rapidly learning to autonomously design and run biological experiments, but the systems intended to govern those capabilities are struggling to keep pace. AI company OpenAI ...